Editorial: Novel biomarkers and extracellular vesicles in endocrine hypertension and related disorders

Front Endocrinol (Lausanne). 2023 Aug 14:14:1262046. doi: 10.3389/fendo.2023.1262046. eCollection 2023.

Cristian A Carvajal^{1

2}, Morag J Young^{3

4}, Damian G Romero^{5

6

7

8}

¹ Department of Endocrinology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
² Center for Translational Research in Endocrinology (CETREN-UC), Pontificia Universidad Católica de Chile, Santiago, Chile.
³ Cardiovascular Endocrinology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
⁴ Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC, Australia.
⁵ Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, United States.
⁶ Mississippi Center of Excellence in Perinatal Research, University of Mississippi Medical Center, Jackson, MS, United States.
⁷ Women's Health Research Center, University of Mississippi Medical Center, Jackson, MS, United States.
⁸ Cardiovascular-Renal Research Center, University of Mississippi Medical Center, Jackson, MS, United States.

No abstract available

Keywords: biomarkers; endocrine hypertension; exosome; extracellular vesicles (EVs); renal disease.

Publication types